Merck logo

Merck

Last updated January 31, 2026
124
Innovation Areas
5,362
Inventors
47
Collaborations

Inadequate cyclic nucleotide signaling: MerckRecent Research Landscape

Insufficient cyclic guanosine monophosphate levels lead to pathological vasoconstriction and tissue damage. Restoring signaling homeostasis prevents chronic organ failure.